In pediatric ALL, two-thirds of BCR-ABL1-positive cases and a lower proportion (<5–25% depending on the subtype) of BCL-ABL1-negative cases carry the IKZF1 deletion [33]. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.